These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8207401)

  • 1. Linear antigenic and immunogenic regions of the respiratory syncytial virus P protein.
    Leonov SV; Utter G; Waris M; Norrby E
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1353-9. PubMed ID: 8207401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear antigenic and immunogenic regions of human respiratory syncytial virus N protein.
    Leonov SV; Waris M; Norrby E
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():357-64. PubMed ID: 7531217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
    Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
    J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo.
    Chargelegue D; Obeid OE; Hsu SC; Shaw MD; Denbury AN; Taylor G; Steward MW
    J Virol; 1998 Mar; 72(3):2040-6. PubMed ID: 9499058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
    Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
    J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
    Palomo C; Cane PA; Melero JA
    J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic structure of human respiratory syncytial virus fusion glycoprotein.
    López JA; Bustos R; Orvell C; Berois M; Arbiza J; García-Barreno B; Melero JA
    J Virol; 1998 Aug; 72(8):6922-8. PubMed ID: 9658147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
    Martínez I; Dopazo J; Melero JA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
    Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
    J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.
    Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
    Acta Microbiol Pol; 1994; 43(3-4):369-79. PubMed ID: 7740987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.
    Hansson M; Ringdahl J; Robert A; Power U; Goetsch L; Nguyen TN; Uhlén M; Ståhl S; Nygren PA
    Immunotechnology; 1999 Mar; 4(3-4):237-52. PubMed ID: 10231093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
    Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
    J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies raised against recombinant respiratory syncytial virus nucleocapsid (N) protein: identification of a region in the carboxy terminus of N involved in the interaction with P protein.
    Murray J; Loney C; Murphy LB; Graham S; Yeo RP
    Virology; 2001 Oct; 289(2):252-61. PubMed ID: 11689048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.
    Akerlind-Stopner B; Utter G; Mufson MA; Orvell C; Lerner RA; Norrby E
    J Virol; 1990 Oct; 64(10):5143-8. PubMed ID: 1697913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
    Johnson S; Oliver C; Prince GA; Hemming VG; Pfarr DS; Wang SC; Dormitzer M; O'Grady J; Koenig S; Tamura JK; Woods R; Bansal G; Couchenour D; Tsao E; Hall WC; Young JF
    J Infect Dis; 1997 Nov; 176(5):1215-24. PubMed ID: 9359721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.
    Jones LP; Zheng HQ; Karron RA; Peret TC; Tsou C; Anderson LJ
    Clin Diagn Lab Immunol; 2002 May; 9(3):633-8. PubMed ID: 11986272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.